These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21306363)

  • 21. Copayments did not reduce medicaid enrollees' nonemergency use of emergency departments.
    Mortensen K
    Health Aff (Millwood); 2010 Sep; 29(9):1643-50. PubMed ID: 20820020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.
    Mann BS; Barnieh L; Tang K; Campbell DJ; Clement F; Hemmelgarn B; Tonelli M; Lorenzetti D; Manns BJ
    PLoS One; 2014; 9(3):e89168. PubMed ID: 24667163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare: looking for pareto optimal changes.
    Christensen S
    Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of copayment policies on initial medication non-adherence according to income: a population-based study.
    Aznar-Lou I; Pottegård A; Fernández A; Peñarrubia-María MT; Serrano-Blanco A; Sabés-Figuera R; Gil-Girbau M; Fajó-Pascual M; Moreno-Peral P; Rubio-Valera M
    BMJ Qual Saf; 2018 Nov; 27(11):878-891. PubMed ID: 29545326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.
    Maciejewski ML; Wansink D; Lindquist JH; Parker JC; Farley JF
    Health Aff (Millwood); 2014 Feb; 33(2):300-8. PubMed ID: 24493774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do medical homes increase medication adherence for persons with multiple chronic conditions?
    Beadles CA; Farley JF; Ellis AR; Lichstein JC; Morrissey JP; DuBard CA; Domino ME
    Med Care; 2015 Feb; 53(2):168-76. PubMed ID: 25517069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?
    Soumerai SB; Ross-Degnan D; Fortess EE; Walser BL
    Milbank Q; 1997; 75(1):11-34. PubMed ID: 9063299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.
    Hershman DL; Tsui J; Meyer J; Glied S; Hillyer GC; Wright JD; Neugut AI
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25349080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling prescription drug expenditures: a report of success.
    Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
    Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicaid policies for HIV-related prescription drugs.
    Buchanan RJ; Smith SR
    Health Care Financ Rev; 1994; 15(3):43-61. PubMed ID: 10137797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.
    Dormuth CR; Neumann P; Maclure M; Glynn RJ; Schneeweiss S
    Med Care; 2009 May; 47(5):508-16. PubMed ID: 19365295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.
    Ritchey M; Tsipas S; Loustalot F; Wozniak G
    PLoS One; 2016; 11(7):e0159366. PubMed ID: 27428008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of switching to a high-deductible health plan on use of chronic medications.
    Reiss SK; Ross-Degnan D; Zhang F; Soumerai SB; Zaslavsky AM; Wharam JF
    Health Serv Res; 2011 Oct; 46(5):1382-401. PubMed ID: 21413983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Cost-Saving Prescription Policy Changes and Adherence to Chronic Disease Medications: an Observational Study.
    Haff N; Sequist TD; Gibson TB; Benevent R; Sears ES; Chaguturu S; Lauffenburger JC
    J Gen Intern Med; 2022 Feb; 37(3):531-538. PubMed ID: 34331213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):825-827. PubMed ID: 31711137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.